Danish Center for Sleep Medicine, Department of Clinical Neurophysiology, University of Copenhagen, Copenhagen, Denmark.
Jazz Pharmaceuticals, Inc., Palo Alto, CA, USA.
Sleep Med. 2021 Aug;84:46-55. doi: 10.1016/j.sleep.2021.05.010. Epub 2021 May 19.
OBJECTIVE/BACKGROUND: Evaluate the impact of excessive daytime sleepiness (EDS) severity on burden of illness among adults with obstructive sleep apnoea (OSA) in European Union 5 (EU5) countries (France, Germany, Italy, Spain, United Kingdom).
PATIENTS/METHODS: This retrospective observational study used data from the 2017 EU5 National Health and Wellness Survey, a self-administered, internet-based, non-screening survey. Respondents who self-reported both having experienced OSA in the last 12 months and having had their OSA diagnosed by a physician were considered to have OSA. Respondents completed the Epworth Sleepiness Scale (ESS) and were consequently categorised into 4 groups: OSA-with-EDS (ESS >10) subdivided by EDS severity (mild [ESS = 11-12], moderate [ESS = 13-15], severe [ESS = 16-24]), and OSA-without-EDS (ESS ≤10). Bivariate and multivariable analyses examined group differences in health-related quality of life (HRQoL), work productivity and activity impairment, and health care utilisation.
The analysis included 2008 respondents with OSA: n = 661 (32.9%) with EDS (29.5% mild, 34.5% moderate, 36.0% severe) and n = 1347 without EDS. Compared with the OSA-without-EDS group, the OSA-with-EDS subgroups generally had higher rates of obesity, depression, and other reported comorbidities. Greater severity of EDS was associated with worse self-reported HRQoL (all domains, P < 0.001) and work productivity and activity impairment (absenteeism, P = 0.031; presenteeism, overall work impairment, and non-work activity impairment, P < 0.001), as well as increased numbers of health care provider visits (P < 0.001).
Compared to patients with OSA but without EDS, those with EDS had substantially higher socioeconomic and humanistic burden of disease, which was more profound among those reporting greater EDS.
目的/背景:评估欧洲 5 国(法国、德国、意大利、西班牙和英国)成年人阻塞性睡眠呼吸暂停(OSA)患者日间嗜睡(EDS)严重程度对疾病负担的影响。
患者/方法:这是一项回顾性观察性研究,使用了 2017 年欧洲 5 国国家健康和健康调查的数据,该调查是一项自我管理的、基于互联网的、非筛查调查。自我报告在过去 12 个月中经历过 OSA 且 OSA 已被医生诊断的受访者被认为患有 OSA。受访者完成了 Epworth 嗜睡量表(ESS),并据此分为 4 组:OSA 伴 EDS(ESS>10),按 EDS 严重程度(轻度[ESS=11-12]、中度[ESS=13-15]、重度[ESS=16-24])细分,以及 OSA 不伴 EDS(ESS≤10)。单变量和多变量分析检查了健康相关生活质量(HRQoL)、工作生产力和活动障碍以及医疗保健利用方面的组间差异。
分析纳入了 2008 名 OSA 患者:n=661 名(32.9%)伴 EDS(29.5%轻度、34.5%中度、36.0%重度),n=1347 名不伴 EDS。与 OSA 不伴 EDS 组相比,OSA 伴 EDS 亚组的肥胖、抑郁和其他报告的合并症发生率通常更高。EDS 严重程度的增加与自我报告的 HRQoL(所有领域,P<0.001)和工作生产力及活动障碍(旷工,P=0.031;工作表现、整体工作障碍和非工作活动障碍,P<0.001)以及就诊次数的增加有关(P<0.001)。
与 OSA 但不伴 EDS 的患者相比,伴 EDS 的患者的社会经济和人文疾病负担明显更高,而 EDS 更严重的患者的负担则更高。